Vaccine. 2007 Dec 5;25(50):8441-7. Epub 2007 Oct 22.

Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties.

Campbell GR, Senkaali D, Watkins J, Esquieu D, Opi S, Yirrell DL, Kaleebu P, Loret EP.

Source

CNRS Formation de Recherche en Evolution 2737, Faculté de Pharmacie, Université de la Méditerranée, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 5, France.

Abstract

Humoral responses against extra-cellular HIV-1 Tat may be beneficial as Tat has been implicated in the viral pathogenesis associated with HIV-1 disease progression. We determined the levels of anti-Tat IgG in sera of HIV-1 seropositive individuals from the Rural Clinical Cohort in Uganda using nine different Tat proteins representative of the major subtypes presently accounting for 97% of infections worldwide. We observed the presence of anti-Tat IgG able to react against the various subtypes tested, although none cross-reacted against all nine variants. We show that 46.25% of seropositive patients were able to recognise at least one Tat variant with 1:1000 sera dilution. We also show that the C terminus of Tat is the most variable region and an important epitope that might explain the limitation of cross-recognition of Tat antibodies regarding Tat variants. This study shows in seropositive patients that Tat can tolerate mutations without modification of its primary function but with changes in its immunogenic properties. These findings should be considered when designing Tat-based HIV-1 vaccines.

PMID:: 17997200; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection. [Biomed Pharmacother. 2003]
Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection.
Richardson MW, Mirchandani J, Duong J, Grimaldo S, Kocieda V, Hendel H, Khalili K, Zagury JF, Rappaport J. Biomed Pharmacother. 2003 Jan; 57(1):4-14.
Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans. [J Infect Dis. 2003]
Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans.
Buttò S, Fiorelli V, Tripiciano A, Ruiz-Alvarez MJ, Scoglio A, Ensoli F, Ciccozzi M, Collacchi B, Sabbatucci M, Cafaro A, et al. J Infect Dis. 2003 Oct 15; 188(8):1171-80. Epub 2003 Sep 30.
HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently. [Vaccine. 2009]
HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently.
Kashi VP, Jacob RA, Paul S, Nayak K, Satish B, Swaminathan S, Satish KS, Ranga U. Vaccine. 2009 Nov 12; 27(48):6739-47. Epub 2009 Sep 8.
Review Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator. [Indian J Biochem Biophys. 2007]
Review Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator.
Gupta S, Mitra D. Indian J Biochem Biophys. 2007 Oct; 44(5):269-75.
Review What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? [Retrovirology. 2009]
Review What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?
Campbell GR, Loret EP. Retrovirology. 2009 May 25; 6:50. Epub 2009 May 25.

See reviews... See all...

Cited by 3 PubMed Central articles

HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells. [J Biol Chem. 2010]
HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells.
Campbell GR, Loret EP, Spector SA. J Biol Chem. 2010 Jan 15; 285(3):1681-91. Epub 2009 Nov 16.
Review What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? [Retrovirology. 2009]
Review What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?
Campbell GR, Loret EP. Retrovirology. 2009 May 25; 6:50. Epub 2009 May 25.
Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant. [Retrovirology. 2008]
Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant.
Watkins JD, Campbell GR, Halimi H, Loret EP. Retrovirology. 2008 Sep 22; 5:83. Epub 2008 Sep 22.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Tat mutations in an African cohort that do not prevent transactivation but chang...
Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties.
Vaccine. 2007 Dec 5 ;25(50):8441-7. Epub 2007 Oct 22 .

PubMed
Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: sta...
Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size.
Pharmacol Res. 2007 Dec ;56(6):531-41. Epub 2007 Oct 2 .

PubMed
First analysis of the long-term results with transrectal HIFU in patients with l...
First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.
Eur Urol. 2008 Jun ;53(6):1194-201. Epub 2007 Nov 5 .

PubMed
Bacteriophage preparation inhibition of reactive oxygen species generation by en...
Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes.
Virus Res. 2008 Feb ;131(2):233-42. Epub 2007 Nov 9 .

PubMed
The impact of bulky upper abdominal disease cephalad to the greater omentum on s...
The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Gynecol Oncol. 2008 Feb ;108(2):287-92. Epub 2007 Nov 13 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information